A Study Comparing Real and Sham Repetitive Transcranial Magnetic Stimulation in Adults With Fibromyalgia, Assessing Effects on Pain, Fatigue, Sleep, Mood, Quality of Life, Cognition, and Walking Under Usual and Dual-task Conditions
Key facts
- Who runs it
- Institute of Rheumatology, Serbia
- Where
- Serbia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 15 Sept 2021
- Ended
- 30 Mar 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active repetitive transcranial magnetic stimulation
- Sham repetitive transcranial magnetic stimulation
- Record updated
- 6 July 2026
Who can take part
- Age
- 30 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Diagnosis of fibromyalgia based on the revised 2016 American College of Rheumatology criteria
- A Visual Analogue Scale pain score of at least 4, with pain present for more than 3 months before inclusion in the study
- Pain resistant to standard analgesics, including paracetamol, nonsteroidal anti-inflammatory drugs, and low-potency opioids, administered at full therapeutic doses
- If receiving treatment for fibromyalgia, participants had to be on a stable dose for more than 1 month before inclusion in the study
- No previous treatment with repetitive transcranial magnetic stimulation
Who cannot take part
- Primary psychiatric diagnosis, including previously diagnosed severe depressive disorder, generalized anxiety disorder, or psychosis
- Other chronic conditions, diseases, or disorders that may cause diffuse pain, such as endocrine or metabolic diseases
- Other degenerative, orthopedic, or surgical diseases of the musculoskeletal system that significantly affect gait, including the use of crutches or a walking cane
- Presence of a chronic inflammatory rheumatic disease
- Presence of a systemic autoimmune disease
- Neurological diseases that have caused or may cause cognitive or motor deficits
- Specific conditions such as active infections, malignancy, osteoporosis with high fracture risk, fractures, and similar conditions
- Contraindications to repetitive transcranial magnetic stimulation, including epilepsy, central nervous system trauma, brain surgery, intracranial hemorrhage, implanted pacemaker or other metal implant, pregnancy, or breastfeeding
- Inability to provide informed consent
- Psychoactive substance abuse
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Fibromyalgia is a chronic condition that causes widespread pain and is often accompanied by fatigue, poor sleep, mood symptoms, memory and concentration difficulties, and reduced quality of life. Many adults with fibromyalgia also experience limitations in daily physical functioning. These limitations may include slower or less stable walking, reduced walking endurance, and greater difficulty walking while performing another task at the same time, such as counting or carrying out a mental task.
Read full original descriptionShow less
This clinical study is designed to evaluate the effects of repetitive transcranial magnetic stimulation, also called rTMS, in adults with fibromyalgia. rTMS is a non-invasive brain stimulation technique that delivers magnetic pulses through the scalp to influence activity in specific brain areas involved in pain processing, mood regulation, and physical function. The procedure does not require surgery or anesthesia.
Participants in this study are randomly assigned to receive either real rTMS or sham rTMS. Sham rTMS is designed to look and feel similar to the real procedure but does not deliver active therapeutic brain stimulation. Comparing real and sham rTMS allows researchers to assess whether any observed improvements are related to the active treatment rather than to expectation or participation in the study.
The study evaluates whether real rTMS can improve symptoms and function in adults with fibromyalgia. Outcomes include pain, fatigue, mood, sleep, quality of life, cognition, and walking performance. Walking is assessed during usual walking and during dual-task walking, when participants walk while also performing another task. These assessments are used to better understand how fibromyalgia affects everyday functioning and whether rTMS may help improve both symptoms and objective physical performance.
The main hypothesis is that participants who receive real rTMS will show greater improvement than those who receive sham rTMS. It is expected that real rTMS may reduce pain and related symptoms, improve quality of life and cognitive or emotional functioning, and have a favorable effect on walking performance, especially under more demanding dual-task conditions.
The 2 groups in the trial
- Active rTMSTreatment being tested
Participants assigned to this arm will receive active repetitive transcranial magnetic stimulation over the left dorsolateral prefrontal cortex. Stimulation will be delivered at 10 Hz and 130% of the individually determined motor threshold. Each session will include 2,000 pulses, delivered as 40 trains of 50 pulses, with 5-second stimulation trains and 20-second inter-train intervals. Treatment will consist of 10 daily sessions over two weeks, administered on working days.
Treatment: Active repetitive transcranial magnetic stimulation
- Sham rTMSSham treatment, for comparison
Participants assigned to this arm will receive sham repetitive transcranial magnetic stimulation over the left dorsolateral prefrontal cortex using a dedicated sham coil. Sham stimulation will reproduce the acoustic characteristics of active rTMS while preventing effective cortical stimulation. The stimulation parameters, number of pulses, train duration, inter-train interval, number of sessions, and treatment schedule were identical to the active rTMS arm.
Treatment: Sham repetitive transcranial magnetic stimulation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Repetitive Transcranial Magnetic Stimulation on Symptoms and Gait in Patients With Primary Fibromyalgia
- Record updated
- 6 July 2026